Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Nukkleus (NUKK) Shares Outstanding (Diluted Average) (2021 - 2025)

Historic Shares Outstanding (Diluted Average) for Nukkleus (NUKK) over the last 5 years, with Q2 2025 value amounting to $5.6 million.

  • Nukkleus' Shares Outstanding (Diluted Average) rose 21372.83% to $5.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $5.6 million, marking a year-over-year increase of 21372.83%. This contributed to the annual value of $2.0 million for FY2024, which is 6230.24% up from last year.
  • Per Nukkleus' latest filing, its Shares Outstanding (Diluted Average) stood at $5.6 million for Q2 2025, which was up 21372.83% from $5.7 million recorded in Q1 2025.
  • Nukkleus' 5-year Shares Outstanding (Diluted Average) high stood at $14.0 million for Q1 2024, and its period low was $1.3 million during Q3 2023.
  • Moreover, its 5-year median value for Shares Outstanding (Diluted Average) was $6.1 million (2021), whereas its average is $7.1 million.
  • In the last 5 years, Nukkleus' Shares Outstanding (Diluted Average) plummeted by 8711.25% in 2023 and then surged by 21372.83% in 2025.
  • Quarter analysis of 5 years shows Nukkleus' Shares Outstanding (Diluted Average) stood at $6.1 million in 2021, then surged by 64.86% to $10.1 million in 2022, then increased by 4.85% to $10.6 million in 2023, then crashed by 80.65% to $2.0 million in 2024, then skyrocketed by 175.15% to $5.6 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $5.6 million for Q2 2025, versus $5.7 million for Q1 2025 and $2.0 million for Q3 2024.